214 related articles for article (PubMed ID: 11919316)
1. Protease inhibitors and mortality among children and adolescents infected with HIV-1.
Barbaro G
N Engl J Med; 2002 Mar; 346(13):1026-7; author reply 1026-7. PubMed ID: 11919316
[No Abstract] [Full Text] [Related]
2. [Antiretroviral therapy in patients infected with HIV-1].
Corti ME
Medicina (B Aires); 1998; 58 Suppl 1():49-56. PubMed ID: 9674248
[No Abstract] [Full Text] [Related]
3. Antiretroviral therapies.
Owen WF
Clin Podiatr Med Surg; 1998 Apr; 15(2):227-39. PubMed ID: 9576051
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.
Gortmaker SL; Hughes M; Cervia J; Brady M; Johnson GM; Seage GR; Song LY; Dankner WM; Oleske JM;
N Engl J Med; 2001 Nov; 345(21):1522-8. PubMed ID: 11794218
[TBL] [Abstract][Full Text] [Related]
5. HIV therapeutics: past, present, and future.
Abu-ata O; Slim J; Perez G; Smith SM
Adv Pharmacol; 2000; 49():1-40. PubMed ID: 11013759
[No Abstract] [Full Text] [Related]
6. Guidelines for the treatment of HIV.
Newsline People AIDS Coalit N Y; 1999 Jan; ():31-3. PubMed ID: 11367185
[TBL] [Abstract][Full Text] [Related]
7. Virological failure and adherence to antiretroviral therapy in HIV-infected patients.
Rodríguez-Rosado R; Jiménez-Nácher I; Soriano V; Antón P; González-Lahoz J
AIDS; 1998 Jun; 12(9):1112-3. PubMed ID: 9662214
[No Abstract] [Full Text] [Related]
8. HIV-1 protease inhibitors.
Eron JJ
Clin Infect Dis; 2000 Jun; 30 Suppl 2():S160-70. PubMed ID: 10860901
[TBL] [Abstract][Full Text] [Related]
9. Amprenavir study results released.
AIDS Patient Care STDS; 1999 Dec; 13(12):754. PubMed ID: 10743545
[No Abstract] [Full Text] [Related]
10. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
11. HIV drug now approved for use with protease inhibitors.
Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335
[No Abstract] [Full Text] [Related]
12. Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate.
Krogstad P; Wiznia A; Luzuriaga K; Dankner W; Nielsen K; Gersten M; Kerr B; Hendricks A; Boczany B; Rosenberg M; Jung D; Spector SA; Bryson Y
Clin Infect Dis; 1999 May; 28(5):1109-18. PubMed ID: 10452644
[TBL] [Abstract][Full Text] [Related]
13. Standard treatments for HIV, Spring 1997.
Smith D
AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
[TBL] [Abstract][Full Text] [Related]
14. [HIV-infected children become adolescents: the Pavia's experience].
Maccabruni A; Bagassi A; Pacati I; Caselli D; Michelone G
Minerva Pediatr; 2001 Oct; 53(5):483-4. PubMed ID: 11668280
[No Abstract] [Full Text] [Related]
15. Vaccination and HIV-1 replication during highly active antiretroviral therapy.
Kroon FP; Beersma MF; Kroes AC; Groeneveld PH; van Dissel JT
AIDS; 1999 Jan; 13(1):135-6. PubMed ID: 10207556
[No Abstract] [Full Text] [Related]
16. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
Tavel JA; Miller KD; Masur H
Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094
[No Abstract] [Full Text] [Related]
17. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
Wilkins E
J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
[No Abstract] [Full Text] [Related]
18. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
[No Abstract] [Full Text] [Related]
19. HIV's potent cocktail.
Lusky K
Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
[No Abstract] [Full Text] [Related]
20. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
Mannheimer SB; Wold N; Gardner EM; Telzak EE; Huppler Hullsiek K; Chesney M; Wu AW; MacArthur RD; Matts J; Friedland G;
Clin Infect Dis; 2008 Mar; 46(6):941-5. PubMed ID: 18279044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
